Company Search:
Advanced Search
Sponsored Links
ImmunoGen, Inc. Company Snapshot
ImmunoGen, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares ImmunoGen with three other companies in this sector in the United States: Alnylam Pharmaceuticals, Inc. (2016 sales of $47.16 million ), China Yct International Group, Inc. ($47.83 million ), and Integrated Biopharma, Inc. ($42.21 million ).

Sales Analysis. During the year ended June of 2016, sales at ImmunoGen were $60.00 million. This is a sharp decrease of 29.9% versus 2015, when the company's sales were $85.54 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ImmunoGen, Inc.
  Stock Performance Chart for ImmunoGen, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 2.43
(Figures in U.S. Dollars)
1 Week -1.6%   13 Weeks 0.0%  
4 Weeks 17.4%   52 Weeks -67.9%  
ImmunoGen, Inc. Key Data:
  Ticker: IMGN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 60,002,000
(Year Ending Jan 2017).
Employees: 385
  Currency: U.S. Dollars Market Cap: 212,142,259
  Fiscal Yr Ends: June Shares Outstanding: 87,301,341
  Share Type: Common Closely Held Shares: 517,942
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.